New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
08:07 EDTGHDXGenomic Health announces positive results of Oncotype DX in colon cancer
Genomic Health announced results from three studies of the Oncotype DX Colon Cancer test at the 2013 Gastrointestinal Cancers Symposium, including new data demonstrating that Recurrence Score results changed treatment recommendations in 45% of the enrolled stage II colon cancer patients. Presentations also include positive findings from a second health economics analysis suggesting that use of the test may result in a significant reduction in direct medical costs and improve patient well-being.
News For GHDX From The Last 14 Days
Check below for free stories on GHDX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 7, 2014
16:20 EDTGHDXGenomic Health sees 2H net losses similar to 1H
Subscribe for More Information
16:19 EDTGHDXGenomic Health reports Q2 EPS (15c), consensus (26c)
Reports Q2 revenue $70.5M, consensus $69.04M. Reports 17% growth in test volume in Q2.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use